Akèy › Kansè kol › Oklahoma › Tulsa
Etid klinik pou Kansè kol nan Tulsa, OK
4 etid pou Kansè kol ap chèche patisipan nan sit nan ak bò kote Tulsa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Ap rekriteFaz 4
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Ap rekriteFaz 3
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001), Tulsa
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Ap rekriteFaz 1/2
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Tulsa
Etid Kansè kol nan lòt vil
- Houston, TX34 etid
- Nashville, TN19 etid
- New York City, NY19 etid
- Boston, MA18 etid
- Los Angeles, CA16 etid
- Arlington, VA16 etid
- San Antonio, TX14 etid
- St. Louis, MO13 etid
- Dallas, TX13 etid
- Orlando, FL12 etid
- Chicago, IL12 etid
- Columbus, OH11 etid
Lòt etid nan Tulsa
- Ensifizyans kadyak10 etid
- Sipwa6 etid
- Obèsite5 etid
- Melanom5 etid
- Akidan serebral iskemi5 etid
- BPCO4 etid
- Maladi Parkinson4 etid
- Stenoz valv aòt4 etid
- Kansè nan tete4 etid
- Kansè Poumon ki pa ti selil4 etid
- Kansè ovè4 etid
- Depresyon4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.